Managed Account Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Managed Account Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$432K	Sell	42,782 -8,853	-17%	-$103K	﹤0.01%	2326
2015 Q1	$692K	Sell	51,635 -4,491	-8%	-$58.9K	﹤0.01%	2190
2014 Q4	$720K	Buy	56,126 +2,957	+6%	+$33.8K	﹤0.01%	2129
2014 Q3	$577K	Buy	53,169 +25,245	+90%	+$289K	﹤0.01%	2157
2014 Q2	$359K	Buy	27,924 +7,763	+39%	+$84.4K	﹤0.01%	2204
2014 Q1	$208K	Buy	+20,161	New	+$227K	﹤0.01%	2238

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Managed Account Advisors's IRWD Position: Q2 2015 in Review

Managed Account Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 17% in Q2 2015, selling an estimated $103K and leaving 42,782 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #2326.

Managed Account Advisors first reported a position in IRWD in Q1 2014 and has held it in 6 quarters since. The position peaked at $720K in Q4 2014. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

Managed Account Advisors held 42,782 shares of Ironwood Pharmaceuticals worth $432K as of Q2 2015.
Managed Account Advisors sold 8,853 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $103K.
Ironwood Pharmaceuticals made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2326 holding.
Managed Account Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2014 and has held it in 6 quarters since.
Managed Account Advisors's Ironwood Pharmaceuticals position peaked at $720K in Q4 2014.
137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.